<DOC>
	<DOCNO>NCT00460785</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence new formulation reference</brief_summary>
	<brief_title>Bioequivalence Trial New Opioid Combination Compared Reference</brief_title>
	<detailed_description />
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Standard Phase I Cyp 2D6 extensive metabolizers Standard Phase I Contraindications current reference tablet SmPC</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>